BIO BLAST PHARMA LTD's ticker is ORPN and the CUSIP is M20156101. A total of 15 filers reported holding BIO BLAST PHARMA LTD in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $8,000 | -27.3% | 13,100 | -8.4% | 0.00% | – |
Q1 2017 | $11,000 | -57.7% | 14,300 | -42.1% | 0.00% | -100.0% |
Q4 2016 | $26,000 | -64.4% | 24,700 | -42.2% | 0.00% | -50.0% |
Q3 2016 | $73,000 | -11.0% | 42,700 | -17.2% | 0.00% | 0.0% |
Q2 2016 | $82,000 | -47.1% | 51,600 | -17.4% | 0.00% | -60.0% |
Q1 2016 | $155,000 | -49.2% | 62,465 | -20.8% | 0.01% | -44.4% |
Q4 2015 | $305,000 | -20.6% | 78,870 | +4.6% | 0.01% | -25.0% |
Q3 2015 | $384,000 | -21.6% | 75,395 | +6.0% | 0.01% | -14.3% |
Q2 2015 | $490,000 | +62.8% | 71,147 | +41.8% | 0.01% | +75.0% |
Q1 2015 | $301,000 | +189.4% | 50,160 | +207.7% | 0.01% | +166.7% |
Q4 2014 | $104,000 | – | 16,299 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 338,110 | $2,330,000 | 0.75% |
Visium Asset Management, LP | 844,000 | $5,815,000 | 0.08% |
OPPENHEIMER & CO INC | 71,147 | $490,000 | 0.01% |
HighTower Advisors, LLC | 36,000 | $248,000 | 0.00% |
DEUTSCHE BANK AG\ | 200 | $1,000 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,000 | $7,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 300 | $2,000 | 0.00% |
UBS Group AG | 3,470 | $24,000 | 0.00% |
CITIGROUP INC | 603 | $4,000 | 0.00% |